Table 1 S100A16 expression (PLI score) and clinicopathological variables of the OSCC patients
| Â | PLI score at invading fronts/islandsa | ||
|---|---|---|---|
Variables | Low, n (%) | High, n (%) | P |
Ageb (years) | |||
 ≤64 | 18 (60.0) | 12 (40.0) | 0.108 |
 >64 | 14 (60.0) | 21 (60.0) |  |
Gender | |||
 Female | 10 (47.6) | 11 (52.4) | 0.857 |
 Male | 22 (50.0) | 22 (50.0) |  |
Location | |||
 Tongue | 14 (45.2) | 17 (54.8) | 0.566 |
 Gingiva, buccal mucosa & oral lip | 11 (47.8) | 12 (52.2) |  |
 Floor of mouth & oro-pharynx | 7 (49.2) | 4 (36.4) |  |
Differentiation | |||
 Poor and moderate | 22 (62.9) | 13 (37.1) | 0.018 |
 Well | 10 (33.3) | 20 (66.7) |  |
Lymph node involvement | |||
 Negative (N0) | 15 (39.5) | 23 (60.5) | 0.062 |
 Positive (N1 & N2) | 17 (63.0) | 10 (37.0) |  |
Tumor size | |||
 T1 & T2 | 19 (52.8) | 17 (47.2) | 0.638 |
 T3 & T4 | 13 (44.8) | 16 (55.2) |  |
Recurrence | |||
 No | 20 (43.5) | 26 (56.5) | 0.149 |
 Yes | 12 (63.2) | 7 (36.8) |  |
Tumor stage | |||
 Early (1 & 2) | 8 (38.1) | 13 (61.9) | 0.215 |
 Late (3 & 4) | 24 (54.5) | 20 (45.5) |  |